239 related articles for article (PubMed ID: 21874315)
1. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Mol Cell Biochem; 2012 Jan; 359(1-2):399-407. PubMed ID: 21874315
[TBL] [Abstract][Full Text] [Related]
2. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2011 Jan; 27(1):3-14. PubMed ID: 21072493
[TBL] [Abstract][Full Text] [Related]
5. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
6. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Mol Cell Biochem; 2011 Sep; 355(1-2):179-86. PubMed ID: 21533765
[TBL] [Abstract][Full Text] [Related]
7. Strontium as therapy for osteoporosis.
Marie PJ
Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
[TBL] [Abstract][Full Text] [Related]
8. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
Brennan TC; Rybchyn MS; Green W; Atwa S; Conigrave AD; Mason RS
Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
Reginster JY; Sarlet N; Lejeune E; Leonori L
Curr Osteoporos Rep; 2005 Mar; 3(1):30-4. PubMed ID: 16036099
[TBL] [Abstract][Full Text] [Related]
12. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways.
Hurtel-Lemaire AS; Mentaverri R; Caudrillier A; Cournarie F; Wattel A; Kamel S; Terwilliger EF; Brown EM; Brazier M
J Biol Chem; 2009 Jan; 284(1):575-584. PubMed ID: 18927086
[TBL] [Abstract][Full Text] [Related]
13. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
Yamaguchi M; Weitzmann MN; Murata T
Mol Cell Biochem; 2012 Jan; 359(1-2):193-203. PubMed ID: 21842421
[TBL] [Abstract][Full Text] [Related]
14. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
Imanishi Y; Nishizawa Y
Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
Marie PJ
Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
[TBL] [Abstract][Full Text] [Related]
17. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
18. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro.
Gentleman E; Fredholm YC; Jell G; Lotfibakhshaiesh N; O'Donnell MD; Hill RG; Stevens MM
Biomaterials; 2010 May; 31(14):3949-56. PubMed ID: 20170952
[TBL] [Abstract][Full Text] [Related]
19. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY
Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
